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Abstract
Background: Bipolar disorder is a severe mental illness with serious consequences for daily living of patients and
their caregivers. Care as usual primarily consists of pharmacotherapy and supportive treatment. However, a
substantial number of patients show a suboptimal response to treatment and still suffer from frequent episodes,
persistent interepisodic symptoms and poor social functioning. Both psychiatric and somatic comorbid disorders
are frequent, especially personality disorders, substance abuse, cardiovascular diseases and diabetes.
Multidisciplinary collaboration of professionals is needed to combine all expertise in order to achieve high-quality
integrated treatment. ‘Collaborative Care’ is a treatment method that could meet these needs. Several studies have
shown promising effects of these integrated treatment programs for patients with bipolar disorder. In this article
we describe a research protocol concerning a study on the effects of Collaborative Care for patients with bipolar
disorder in the Netherlands.
Methods/design: The study concerns a two-armed cluster randomised clinical trial to evaluate the effectiveness of
Collaborative Care (CC) in comparison with Care as usual (CAU) in outpatient clinics for bipolar disorder or mood
disorders in general. Collaborative Care includes individually tailored interventions, aimed at personal goals set by the
patient. The patient, his caregiver, the nurse and the psychiatrist all are part of the Collaborative Care team. Elements
of the program are: contracting and shared decision making; psycho education; problem solving treatment;
systematic relapse prevention; monitoring of outcomes and pharmacotherapy. Nurses coordinate the program.
Nurses and psychiatrists in the intervention group will be trained in the intervention. The effects will be measured at
baseline, 6 months and 12 months. Primary outcomes are psychosocial functioning, psychiatric symptoms, and
quality of life. Caregiver outcomes are burden and satisfaction with care.
Discussion: Several ways to enhance the quality of this study are described, as well as some limitations caused by
the complexities of naturalistic treatment settings where not all influencing factors on an intervention and the
outcomes can be controlled.
Trial Registration: The Netherlands Trial Registry, NTR2600.
Background
Bipolar disorder is a severe mental illness with an esti-
mated lifetime prevalence of 1.5 to 2%[1]. It is character-
ized by recurrent episodes of extreme mood changes.
Several studies [2-4] show that on average patients suffer
from manic, depressive, hypomanic or mixed symptoms
for about half of the time despite treatment. Even during
so-called euthymic periods, i.e. when they are formally
not in a mood episode, many patients suffer from subsyn-
dromal symptoms that negatively influence their quality
of life [5]. Informal caregivers also suffer a substantial
burden by the illness, not only during episodes [6,7].
Treatment of bipolar disorders in the Netherlands pri-
marily consists of pharmacotherapy, supportive treat-
ment, and psycho education, sometimes combined with
improvement of self-management skills or psychother-
apy. Many patients respond well to this treatment and
may stabilize for longer periods. However, a substantial
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treatment efforts. They suffer from frequent episodes,
persisting symptoms, cognitive problems, limited social
support and poor social functioning. Comorbid psychia-
tric disorders, such as personality disorders and sub-
stance abuse, are common, as are somatic disorders i.e.
cardiovascular disease, partly associated with prolonged
use of maintenance medication [8,9].
Multidisciplinary collaboration of professionals is needed
to involve optimal specialist skills on all aspects of the dis-
order, and to properly combine all expertise in order to
achieve an optimally integrated care [10]. The Dutch
guideline for the treatment of bipolar disorders [11]
recommends such an integrated treatment. The guideline
advises that treatment be targeted at reducing symptoms,
acceptance of the illness, promoting treatment adherence,
stabilising social rhythm, recognising early signs and
symptoms and take proper actions when these occur,
diminishing social problems and maximising social partici-
pation. It is advised to actively engage caregivers or family
members in this treatment. Although it is widely acknowl-
edged that integrated treatment programs can be of great
value for patients with bipolar disorder, research on the
effectiveness of such programs for patients with a bipolar
disorder is scarce.
Collaborative Care (CC) programs have been developed
to integrate multidisciplinary care for complex disorders
and to date, three research projects show promising results
with bipolar patients. Bauer et al. [12,13] have implemen-
ted a CC model for patients with bipolar disorder and
measured the effects in two randomised controlled trials.
Patients participated in the Life Goals Program. The inter-
vention consisted of improving patients’ self-management
skills through psycho education; supporting providers’
decision making through simplified practice guidelines;
and enhancing access to care and continuity of care. The
care manager, a nurse or a social worker, provided actively
outreaching care when a patient was at risk of losing con-
tact with mental health workers. Each patient made a
‘relapse prevention plan’, aimed at the early recognition of
relapses. The care manger contacted the patient at least
every three months. The program also provides guidelines
for specific pharmacotherapy. Bauer et al. [12,13] found
significantly reduced number of weeks in manic episodes
in the experimental group, although no significant effect
was found on weeks depressed. Patients showed improved
social functioning, quality of life and treatment satisfac-
tion. Total costs were similar in both groups. The Life
Goals Program was extended by Kilbourne et al. [14,15],
to address the many medical comorbidities present in
patients with bipolar disorders.
Simon et al. [16,17] have explored the effects of adding
intensive nursing care to treatment of patients with bipolar
disorder. This consisted of an emergency plan, monthly
telephone calls in which symptoms were monitored, shar-
ing of information between nurse and psychiatrist, and
outreach interventions such as crisis intervention. Patients
were given the choice of participation in the Life Goals
Program, mentioned above. After receiving the interven-
tion over a period of one or two years, patients in the
experimental group showed significant less severe manic
symptoms of shorter duration. Also in this study, there
was no effect on depressive symptoms. Extra costs of this
treatment were relatively low compared to the control
group.
Suppes et al. [18] studied the effects of the Texas Medi-
cation Algorithm project in patients with bipolar disorder.
This project aimed to develop and implement algorithms
for pharmacotherapy for bipolar patients. Clinics imple-
menting this guideline were compared in a RCT to clinics
which did not use the guideline. In the experimental
group, a coordinator was added to the care team. This
coordinator provided psycho education to the patient and
the family. He kept in contact with the patient, and
assessed symptoms and side effects of medication prior to
each consultation with the psychiatrist. The coordinator
informed the psychiatrist about the results of these assess-
ments. The aim was to achieve a higher efficiency of the
psychiatric consultations. The results of the study show a
significant improvement of psychiatric symptoms of
patients in the intervention group in the first three
months. During the next nine months, patients in the con-
trol group improved as well, but less than patients in the
intervention group. Patients in the intervention group
reported significant improvement of manic, but not
depressive and psychotic symptoms.
It is striking that all three studies show improvement
of manic but not depressive symptoms.
In the Netherlands, until now no studies have been per-
formed on the effects of CC for patients with bipolar dis-
order. The current study will be the first to implement CC
for patients with bipolar disorder, and moreover, to add a
specific intervention to improve depression. Furthermore,
CC appears to offer good possibilities to strengthen the
position of the nurse in the care process for patients with
a bipolar disorder, both at the organizational and content
levels.
In this article we describe the study protocol for inves-
tigating the effectiveness of a CC program for patients
with bipolar disorder. We set out the following three
research questions to answer:
A What are the effects of a CC program, compared to
Care as Usual (CAU), for patients with bipolar disorder,
with regard to their psychosocial functioning, psychiatric
symptoms, quality of life, attitudes towards medication,
mastery, and satisfaction with care?
B What are the effects of a CC program, compared to
CAU, for informal caregivers of patients with a bipolar
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satisfaction with care?
C What is the cost effectiveness of a CC Program
compared to CAU?
Methods/design
Design
A pragmatic two-armed cluster randomized controlled
trial (RCT) will be carried out in mental health outpatient
clinics in the Netherlands. A Collaborative Care program
will be executed in the experimental condition, whereas
the control condition will continue to deliver Care as
Usual (CAU). CC will be performed by the CC-team, with
mental health nurses in a coordinating role. Baseline mea-
surements will be obtained at inclusion and follow-up
measurements will take place at 6 months and 12 months.
The primary outcome measures are psychosocial function-
ing, symptoms, and quality of life. Secondary outcome
measures are mastery, attitude towards medication and
satisfaction with care. Family members or friends of
patients will be asked to fill in questionnaires regarding
perceived burden and satisfaction with care.
Study on Care as Usual
The level of CAU may vary considerably among the var-
ious outpatients clinics in the Netherlands, and there is a
lack of clarity about the specific content of CAU for
patients with bipolar disorder. However, there is more
detailed knowledge available about care provided in some
highly specialized centres for patients with bipolar disorder
that may resemble CC. In the Netherlands, about 20.000
patients receive care for bipolar disorder but it is estimated
that only 1500 patients receive this care in these specia-
lized centres. Hence, about 18.500 patients receive CAU at
a less specific level. Our presumption is that CC will differ
considerably from CAU, which we expect to be mainly
supportive and not systematically delivered. In order to
increase our knowledge about the characteristics of CAU
another study has started to describe current CAU for
bipolar disorders in the Netherlands. In this study, psy-
chiatrists and patients are being asked to describe the care
actually delivered to patients with bipolar disorder, by
means of questionnaires. These data will be used in the
current study: (1) to objectively describe CAU; (2) to select
sites (based on our inclusion criteria) that can be included
in our CC-trial; and (3) to perform the matching of sites
for the (cluster) randomization. Furthermore, if outpatient
care teams are interested in participating in the CC-trial,
we will interview two members of that team to investigate
t h en a t u r ea n di n t e n s i t yo fc are currently delivered to
patients with bipolar disorder. Clinics that currently have
a level of CAU that does not already resemble CC can be
considered for randomisation.
Randomisation
In this trial we will use clustered randomisation with out-
patient clinic teams as clusters. Randomisation will be per-
formed as follows: the CAU-study as well as the interviews
with team members provide us with insight in the nature
and intensity of CAU at that site. This enables us to
describe CAU more precisely and formulate criteria for
inclusion. Sites that meet the criteria for CAU will be
invited to join in the CC-trial. Teams will be matched for
characteristics of care offered to bipolar patients, as well as
organisational characteristics such as team composition or
type of organisation. One team of every pair will be ran-
domly assigned to the experimental condition, and the
other to the control condition. Patients in both teams who
meet the inclusion criteria will be asked to participate in
the study.
Respondents
Patients who meet the following inclusion criteria will
be included:
￿ diagnosis of bipolar disorder according to DSM-
IV-TR [19];
￿ age 18-65 years.
Exclusion criteria:
￿ Acute phase of severe depression or mania (CGI-
BP: degree of illness score 6 or score 7).
￿ A very stable course of illness (during the last year)
that allows low intensity of treatment (2-4 consults
with the psychiatrist per year suffice), to be judged
by the treating psychiatrist.
￿ Insufficient command of the Dutch language.
￿ Not able or willing to give informed consent.
If the patient consents, a family member or friend will
also be asked to participate in the study, according to
the following inclusion criteria:
￿ T h ef a m i l ym e m b e ro rf r i e n di sa s s i g n e db yt h e
patient.
￿ The family member or friend is 18 years or older.
￿ The family member or friend has a sufficient com-
mand of the Dutch language.
￿ The family member or friend is able and willing to
give informed consent.
Blinding
S i n c et h ec u r r e n ts t u d yi sap r a g m a t i ci n t e r v e n t i o n
study, blinding of patients and professionals for care
modality is not possible. However, blinding is performed
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analysis. Furthermore, the research assistant who per-
forms interviews by telephone to administer the Life
Chart, will be blind to the condition of the respondent.
The intervention
CC will be recovery-oriented, meaning that it supports
the personal process of the patient towards redefining
and achieving his goals in life despite the disorder. It
will consist of the following systematically delivered ele-
ments of treatment:
￿ The formation of a Collaborative Care team,
including at least the patient, the nurse and the psy-
chiatrist, were all decisions concerning treatment
and care will be made, using shared decision making.
If possible, a family member or friend will be
engaged in the treatment and be part of the CC
team. Teams meet every three months. Coordination
of care and continuity of care is provided by the
nurse.
￿ Contracting. Agreement on the most important
problems to be worked on, and on which treatment
is needed to help the patient achieve his personal
goals, will be striven for. A treatment plan will be
made, formulated as a contract, in which goals and
treatment activities are recorded.
￿ Working with the treatment plan based on sys-
tematic care needs assessment, and that will focus
specifically on recovery-oriented goals, defined by
the patient. Systematic monitoring of outcomes.
￿ Psycho education [20,21]), provided as a course
directed at a group of patients and caregivers.
￿ Problem Solving Treatment (PST) [22,23], deliv-
ered by the nurse.
￿ Mood charting by means of the Life Chart Method
[24] and recognising early warning signs of relapse
[25-27].
￿ Pharmacotherapy and somatic care, as usual. In
addition, structured and continuous monitoring of
the effects.
￿ If indicated, specialised PST will be delivered (1) to
patients who remain depressed, aimed at increasing
the amount of pleasant or fulfilling activities, and (2)
to patients with wishes or care needs on the subject
of participation in society, aimed at rehabilitation.
These interventions will be tailored to the individual
needs of the patient.
In the CC trial, CC will be implemented in the experi-
mental teams by the use of the Replicating Effective Pro-
grams framework (REP) [28]. This framework appears to
be well-suited for the implementation of our program as
it specifies steps needed to maximise fidelity while
allowing opportunities for flexibility. REP consists of four
phases: pre-conditions (e.g., identifying need, target
population, and suitable intervention), pre-implementa-
tion (e.g., intervention packaging), implementation (e.g.,
package dissemination, training, technical assistance, and
evaluation), and maintenance and evolution (e.g., prepar-
ing the intervention for sustainability). Key components
of REP, including intervention packaging, training, tech-
nical assistance, and fidelity assessment are crucial to the
implementation of effective interventions in health care.
A manual-based training program will be developed by
the researchers with assistance of an expert panel consist-
ing of expert nurses, psychiatrists, patients and family
members. Nurses in the experimental condition will
receive a three-day training program, and psychiatrists and
psychologists will receive parts of this training. The trained
teams will perform CC during one year. They will be pri-
marily responsible for the coordination and continuity of
treatment and care for patients with bipolar disorder. The
primary investigator (TV) will supervise the nurses inten-
sively during the performing stage of the intervention, by
weekly contact by telephone and regular meetings in the
facility with colleagues who also participate in the study.
Fidelity will be assessed by means of checklists filled out
by the nurses in the experimental group, and by randomly
checking the electronic files of patients, by the primary
investigator.
Nurses in the control group will be performing Care
As Usual, of which the content will be assessed by the
researcher at baseline, by means of the checklist men-
tioned before. The Care consumption will be measured
with the TIC-P questionnaire in both groups.
Measures (Table 1)
Measurements will take place at baseline and after 6 and
12 months of follow-up in patients, clinicians and family
members or friends of the patients. All questionnaires are
available in Dutch. At baseline, demographics, illness his-
tory and current characteristics of bipolar disorder will be
recorded with the Questionnaire for Bipolar Illness (QBP-
NL), that has been used previously in a large naturalistic
cohort study [29,30]. We will measure overall functioning
with the Functioning Assessment Short Test (FAST-NL-
P). This questionnaire has been shown to have good psy-
chometric proportions [31]. The current severity of the
disorder will be measured with the Clinical Global Impres-
sion for Bipolar Disorder (CGI-BP) [32], rating manic and
depressive symptoms separately, as well as the overall
severity of bipolar disorder. Symptoms will be assessed
with the Brief Symptom Inventory (BSI), which is the
short version of the SCL-90 [33] and shows good psycho-
metric proportions. Patients will fill in the BSI, which
takes about 10 minutes to complete. Depressive symptoms
will be measured with the Quick Inventory for Depressive
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excellent psychometric proportions [11]. Manic symptoms
will be assessed with the Altman Self Rating Mania Scale
(ASRM), which has shown satisfying psychometric quali-
ties [34]. Course of illness and recurrences of mood epi-
sodes will be assessed with the Life Chart Method [35]
during a telephone interview by a research assistant [36].
Quality of life will be assessed with the World Health
Organisation Quality of Life -short version (WHOQoL-
Bref), a widely used instrument with good psychometric
proportions [37]. Assessment of needs will be measured
by the CANSAS-P [38], of which validity and reliability
proved to be satisfying [39,40]. Mastery will be measured
with the Sense of Mastery Scale, which is widely used and
is found valid and reliable [41]. Satisfaction with care will
be measured with a Visual Analogue Scale (VAS), and
c o s t sw i t ht h eT i C - P[ 4 2 ] .I n f o r m a t i o no nA t t i t u d eo n
Drugs will be gathered with the Drugs Attitude Inventory
(DAI-10) [43], which has been proved valid. Burden per-
ceived by caregivers will be assessed with the Involvement
Evaluation Questionnaire (IEQ), a self report list which is
widely used and has been found valid [44]. Caregivers will
also be asked to score satisfaction with care on a Visual
Analogue Scale (VAS).
Statistical analysis
Primary outcomes are psychosocial functioning; course,
prevalence and severity of psychiatric symptoms and
quality of life.
Data will be analyzed according to the intention to
treat-principle. Baseline comparability of the experimen-
tal and control groups in demographic and clinical
variables will be evaluated with ANOVA/independent
samples t-test and Chi-square tests. Differences in out-
come between CC and CAU will be evaluated by means
of (mixed model) analysis of covariance. A group*time-
interaction term will be entered into the model to test
for a difference in treatment effect over time. In analyz-
ing a specific outcome variable, the baseline score of
that variable will be used as covariate. The analysis will
be extended using multilevel analysis that takes the nest-
ing of measurements into account. In the multilevel
analyses we consider location as the first level, patient
as the second level, and the three measurements as a
third level, using the principles of Twisk [45]. Finally we
will take into account to what extent patients were
exposed to the intervention by analysing the dose-effect
relationship.
Power calculation
The power calculation concerns the comparison at T12
compared to T0 between the two groups (CC vs. CAU).
We were not able to detect studies sufficiently compar-
able to ours to find a basis for estimating an effect size.
We assume the effect size Cohen’s d = 0,5, because we
consider this a clinically relevant effect. Setting a <. 0 5
(two-tailed), and the power (1-b)=. 8 0 ,t h er e q u i r e d
sample size is 2 × 63 patients. In cases of clustered ran-
domisation the standard is to add 25% to this amount
(n = 2 × 79). Taking into account an expected loss of
30%, a sample of 103 patients in each group is needed.
Ethical considerations
This study protocol has been reviewed by the Scientific
Committee of the EMGO Institute of VU University
Medical Center in Amsterdam, The Netherlands, and by
the Research Committee of Inholland University for
Applied Sciences, Amsterdam, and has been approved
for by the Medical Ethical Committee of the VU Univer-
sity Medical Centre for final approval. Patients will
obtain oral and written information about the study and
will be asked to sign an informed consent form if they
are willing to participate. They will give informed con-
sent for participation of a specific caregiver, who will
also be asked to give separate informed consent.
Discussion
This pragmatic trial will to our knowledge be the first to
evaluate the effectiveness of recovery oriented Colla-
borative Care for patients with bipolar disorder outside
the United States. Our study will assess primarily the
effects of CC on functioning, psychiatric symptoms and
quality of life. We expect that CC contributes to an
increased quality of care for these patients.
The quality of the study is enhanced in four ways.
Firstly, we included the expertise of patients, informal
Table 1 Measures in experimental group as well as in
control group
Instrument Filled in by T0 T6 T12
QBP-NL p/c X
CGI-BP C X x X
BSI P X x X
IDS-SR P X x X
ASRM P X x X
LIFE P X x X
FAST P X x X
WHOQoL-bref P X x X
CANSAS P X x X
Mastery P X x X
TIC-P P X x X
DAI-10 P X x X
IEQ F X x X
VAS p/f X x X
P = patient; F = family or friend (informal caregiver); C = Clinician or
professional caregiver (psychiatrist or psychologist)
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development of the CC intervention. Secondly, we care-
fully planned implementation of CC in the experimental
group, with the three days of training, weekly coaching
for the nurses, regular meetings with the group of
nurses that perform CC, and fidelity assessments. In this
way we intend to improve intervention compliance in
the experimental group. Thirdly, we apply very few a
priori exclusion criteria, hence we will be able to gener-
alise our findings to a large group of outpatients with
bipolar disorder. Finally, the interviewing research assis-
tant is blinded for the treatment condition of the
respondents, while administering the Life Chart by
telephone.
Besides these strong points, this study has some limita-
tions, which should be acknowledged. The main limita-
tion is that patients and professional care providers
cannot be blinded for the treatment condition to which
they will be randomised. This is a possible source of bias,
as patients as well as nurses in the intervention group
may be more actively involved in the treatment because
they expect it to work, which may enhance the effect of
the intervention we find. A second limitation is the possi-
bility that participation in the study and being exposed to
follow-up assessments may affect the outcome of the
CAU control group. This may decrease the contrast
between the two groups and thus the probability to find
statistically significant differences between the CC and
the CAU condition. The third limitation is that it is not
possible to discern which component of CC contributed
to the effect.
Limitations of this kind are inevitable in a pragmatic
trial, because of the complexities of naturalistic treat-
ment settings where not all influencing factors on our
intervention and the outcomes can be controlled.
Despite this, we hypothesize that this program will
improve the quality of care for patients with bipolar dis-
order, thereby optimizing symptomatic recovery, level of
functioning and in the end their quality of life.
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